Enterprise Value
16.0M
Cash
104.2M
Avg Qtr Burn
-6.867M
Short % of Float
2.93%
Insider Ownership
1.63%
Institutional Own.
88.96%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CTI-1601 Details Rare diseases, Rare genetic disease, Friedreich’s Ataxia | Phase 2 Data readout |